Welcome - CNS - Validated tests an QA
Founded in 1996 - CNS focus - Validated tests - Quality - Customers - Publications
Therapeutic area - Methods - Disease Models - Programs - Research Collaboration Contract Research - Research Partner - Research Collaboration - QA Program - Confidentiality and IP Rights Sign-up for mailing list - Examples of newsletters Contact us
Search engine
PRECLINICAL RESEARCH
FORCED SWIMMING TEST
ANIMAL MODEL OF DEPRESSION
PDF file
Introduction
Compound testing
Animals placed in a container filled with water show periods of increased swimming activity and periods of relative immobility. Clinically active anti-depressants have been found to delay the onset of the first phase of immobility and to reduce the total time of relative immobility. The list of active compounds includes monoamino-oxidase-A (MAO-A) inhibitors such as moclobemide, brofaromine, noradrenaline (NA) uptake inhibitors such as imipramine and amytryptilin, MAO-B inhibitors such as selegiline and tranylcypromine, serotonin uptake inhibitors (SSRI) such as fluoxetine and paroxetine and combined NA / SSRI such as venlafaxine. Benzodiazepines and other types of psychoactive compounds have been found to be inactive in this test.
Compound testing addresses the effect of acute treatment (typically 15 - 60 min before the implementation of the test) on the immobility time of mice.
Investigation of the effect of subchronic treatment is also possible.
Antidepressant effect of Imipramine given IP to Swiss mice 30 min before the test
and of Diazepam given PO 60 min before the test
* means p
0.05 versus control group.
References
Porsolt RD, Bertin A, Jaffre M. Behavioral despair in rats and mice: strain differences and the effect of imipramine. Eur J Pharmacol. 1978, 51:291-294.
Borsini F and Meli A. Is the forced swimming test a suitable model for revealing an-tidepressant activity ? Psychopharmacol. 1988, 94:147-160.